Improve Oncology Clinical Trial Readiness for Faster Proof-of-Concept
Join Luke Gill and Dr. Yong Wang for a webinar on adaptive strategies—Bayesian designs, master protocols, and real‑world evidence—that tackle rising costs and low success rates. Learn how these data‑driven approaches accelerate proof‑of‑concept, de‑risk development, and enable earlier China integration into global clinical pathways to compress timelines and boost regulatory success. Register to watch.
The Glomerular Revolution: Understanding the New Wave of Breakthroughs in Rare Kidney Diseases
Watch Professor Jonathan Barratt, PhD, FRCP, and Claudio Hegenberger, VP Scientific & Medical Affairs, as they explore the latest therapies, emerging disease subtypes, and the growing role of combination treatments in adults and children.
Learn how the “Glomerular Revolution” is reshaping diagnosis and care for IgAN, FSGS and beyond.